Top compounds associated with response to SLC4A9


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0069 0.8
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.0064 0.8
mRNA GDC-0449 GDSC1000 pan-cancer AAC 0.0076 0.8
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA A-770041 GDSC1000 pan-cancer AAC 0.011 0.8
mRNA Imatinib CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.0073 0.8
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA lapatinib GDSC1000 pan-cancer AAC -0.0097 0.8
Download CSV